HEPATIC AMOEBIASIS

HEPATIC AMOEBIASIS was reported 67 times

These drug classes are most commonly taken by patients reporting HEPATIC AMOEBIASIS:

# Drug Count
0 Corticosteroid [EPC] 26
1 Nitroimidazole Antimicrobial [EPC] 13
2 CD20-directed Cytolytic Antibody [EPC] 12
3 Alkylating Drug [EPC] 8
4 Tumor Necrosis Factor Blocker [EPC] 7
5 Antimalarial [EPC] 6
6 Antiprotozoal [EPC] 6
7 Dihydrofolate Reductase Inhibitor Antimalarial [EPC] 6
8 Platinum-based Drug [EPC] 6
9 Antimetabolite Immunosuppressant [EPC] 5
10 Fluoroquinolone Antibacterial [EPC] 5
11 Nucleoside Analog Antiviral [EPC] 5
12 SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] 5
13 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 4
14 Cytochrome P450 3A Inhibitor [EPC] 3
15 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 3
16 Protease Inhibitor [EPC] 3
17 Purine Antimetabolite [EPC] 3
18 Azole Antifungal [EPC] 2
19 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 2
20 Microtubule Inhibitor [EPC] 2
21 Nonsteroidal Anti-inflammatory Drug [EPC] 2
22 Nucleoside Metabolic Inhibitor [EPC] 2
23 Penem Antibacterial [EPC] 2
24 Sulfonamide Antimicrobial [EPC] 2
25 Angiotensin 2 Receptor Blocker [EPC] 1
26 Antimycobacterial [EPC] 1
27 Benzodiazepine [EPC] 1
28 Cardiac Glycoside [EPC] 1
29 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1
30 Expectorant [EPC] 1
31 Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1
32 Interleukin-12 Antagonist [EPC] 1
33 Interleukin-23 Antagonist [EPC] 1
34 Lipopeptide Antibacterial [EPC] 1
35 Osmotic Laxative [EPC] 1
36 Thalidomide Analog [EPC] 1
37 Vitamin B12 [EPC] 1
38 Vitamin C [EPC] 1
39 Vitamin D [EPC] 1